 Holly Lutz
Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parasites | 5 | 2021 | 50 | 1.590 |
Why?
| | Chiroptera | 4 | 2023 | 56 | 1.500 |
Why?
| | Birds | 9 | 2023 | 93 | 1.420 |
Why?
| | Haemosporida | 5 | 2019 | 8 | 1.330 |
Why?
| | Host-Parasite Interactions | 5 | 2021 | 114 | 0.910 |
Why?
| | Malaria, Avian | 3 | 2019 | 4 | 0.830 |
Why?
| | Microbiota | 4 | 2023 | 762 | 0.750 |
Why?
| | Diptera | 1 | 2021 | 30 | 0.710 |
Why?
| | Plasmodium | 2 | 2019 | 13 | 0.670 |
Why?
| | Phylogeny | 9 | 2023 | 904 | 0.630 |
Why?
| | Life Cycle Stages | 2 | 2016 | 41 | 0.580 |
Why?
| | Genome, Protozoan | 1 | 2016 | 3 | 0.530 |
Why?
| | Rodentia | 1 | 2016 | 57 | 0.490 |
Why?
| | Biological Evolution | 3 | 2025 | 474 | 0.470 |
Why?
| | Primates | 1 | 2016 | 126 | 0.460 |
Why?
| | Gastrointestinal Microbiome | 4 | 2024 | 697 | 0.420 |
Why?
| | Communicable Diseases, Emerging | 2 | 2025 | 36 | 0.400 |
Why?
| | Biodiversity | 2 | 2021 | 409 | 0.390 |
Why?
| | Bird Diseases | 2 | 2019 | 12 | 0.280 |
Why?
| | Zoonoses | 2 | 2025 | 33 | 0.270 |
Why?
| | Bayes Theorem | 4 | 2019 | 405 | 0.260 |
Why?
| | Animals | 18 | 2025 | 36940 | 0.260 |
Why?
| | Animals, Wild | 2 | 2023 | 59 | 0.250 |
Why?
| | RNA Viruses | 1 | 2025 | 43 | 0.220 |
Why?
| | Likelihood Functions | 2 | 2016 | 144 | 0.220 |
Why?
| | Bottle-Nosed Dolphin | 1 | 2024 | 4 | 0.220 |
Why?
| | Familial Mediterranean Fever | 1 | 2021 | 8 | 0.180 |
Why?
| | Amyloidosis | 1 | 2021 | 42 | 0.180 |
Why?
| | Starfish | 1 | 2020 | 2 | 0.180 |
Why?
| | Densovirus | 1 | 2020 | 4 | 0.180 |
Why?
| | Public Health Surveillance | 1 | 2021 | 82 | 0.170 |
Why?
| | Eukaryota | 1 | 2021 | 57 | 0.170 |
Why?
| | Community Networks | 1 | 2021 | 58 | 0.170 |
Why?
| | Communicable Disease Control | 1 | 2021 | 82 | 0.170 |
Why?
| | Symbiosis | 1 | 2021 | 79 | 0.170 |
Why?
| | Biological Specimen Banks | 1 | 2021 | 102 | 0.170 |
Why?
| | Vertebrates | 1 | 2020 | 60 | 0.160 |
Why?
| | Microglia | 1 | 2021 | 251 | 0.150 |
Why?
| | Amyloid beta-Peptides | 1 | 2021 | 220 | 0.150 |
Why?
| | Bacteria | 2 | 2023 | 858 | 0.140 |
Why?
| | Ecology | 1 | 2019 | 118 | 0.140 |
Why?
| | South America | 2 | 2019 | 60 | 0.140 |
Why?
| | Laser Capture Microdissection | 1 | 2016 | 33 | 0.130 |
Why?
| | Africa, Eastern | 1 | 2016 | 12 | 0.130 |
Why?
| | Metagenome | 3 | 2022 | 147 | 0.120 |
Why?
| | Disease Vectors | 1 | 2015 | 16 | 0.120 |
Why?
| | Protozoan Infections, Animal | 1 | 2015 | 4 | 0.120 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1062 | 0.100 |
Why?
| | Fecal Microbiota Transplantation | 2 | 2024 | 23 | 0.100 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 200 | 0.090 |
Why?
| | Behavior, Animal | 1 | 2015 | 501 | 0.090 |
Why?
| | Climate Change | 1 | 2013 | 183 | 0.090 |
Why?
| | Models, Genetic | 1 | 2013 | 600 | 0.080 |
Why?
| | Geography | 2 | 2021 | 200 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 812 | 0.080 |
Why?
| | Cell Nucleus | 1 | 2013 | 620 | 0.080 |
Why?
| | Metagenomics | 2 | 2022 | 169 | 0.080 |
Why?
| | Ecosystem | 1 | 2015 | 596 | 0.080 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2023 | 549 | 0.080 |
Why?
| | Brain | 1 | 2021 | 2668 | 0.080 |
Why?
| | Feces | 2 | 2024 | 484 | 0.080 |
Why?
| | Host Specificity | 2 | 2019 | 29 | 0.080 |
Why?
| | Prevalence | 1 | 2015 | 2734 | 0.070 |
Why?
| | Endemic Diseases | 1 | 2025 | 32 | 0.060 |
Why?
| | Madagascar | 1 | 2023 | 48 | 0.050 |
Why?
| | Africa | 1 | 2023 | 108 | 0.050 |
Why?
| | Reference Standards | 1 | 2023 | 186 | 0.050 |
Why?
| | Body Size | 1 | 2023 | 108 | 0.050 |
Why?
| | Gene Ontology | 1 | 2021 | 53 | 0.050 |
Why?
| | Pyrin | 1 | 2021 | 3 | 0.050 |
Why?
| | Turkey | 1 | 2021 | 22 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2025 | 493 | 0.040 |
Why?
| | Viral Tropism | 1 | 2020 | 31 | 0.040 |
Why?
| | Chemokines | 1 | 2021 | 228 | 0.040 |
Why?
| | Soil | 1 | 2022 | 230 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2020 | 225 | 0.040 |
Why?
| | Disaster Planning | 1 | 2021 | 91 | 0.040 |
Why?
| | Genome, Viral | 1 | 2020 | 144 | 0.040 |
Why?
| | Antibodies | 1 | 2021 | 410 | 0.040 |
Why?
| | Alaska | 1 | 2019 | 83 | 0.040 |
Why?
| | Probability | 1 | 2019 | 304 | 0.040 |
Why?
| | Viral Proteins | 1 | 2020 | 342 | 0.040 |
Why?
| | Global Health | 1 | 2021 | 386 | 0.040 |
Why?
| | Species Specificity | 1 | 2019 | 585 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2167 | 0.030 |
Why?
| | Public Health | 1 | 2021 | 588 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2071 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 991 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 644 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1774 | 0.030 |
Why?
| | Transcriptome | 1 | 2020 | 971 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.030 |
Why?
| | Humans | 5 | 2025 | 137585 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1639 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3457 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7604 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5757 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5742 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3958 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10811 | 0.020 |
Why?
| | Mice | 1 | 2021 | 17787 | 0.010 |
Why?
| | Child | 1 | 2021 | 21935 | 0.010 |
Why?
| | Male | 1 | 2021 | 67762 | 0.010 |
Why?
| | Female | 1 | 2021 | 73304 | 0.010 |
Why?
|
|
Lutz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|